Distinct patterns of serum hepatitis B core-related antigen during the natural history of chronic hepatitis B

Por Zhang, Zhan-Qing, Zhang, Xiao-Nan, Lu, Wei, Wang, Yan-Bing, Weng, Qi-Cheng, Feng, Yan-Ling
Publicado no BMC Gastroenterol (2017)

On-treatment quantitative hepatitis B e antigen predicted response to nucleos(t)ide analogues in chronic hepatitis B

Por Gao, Yu-Hua, Meng, Qing-Hua, Zhang, Zhan-Qing, Zhao, Ping, Shang, Qing-Hua, Yuan, Quan, Li, Yao, Deng, Juan, Li, Tong, Liu, Xue-En, Zhuang, Hui
Publicado no World J Hepatol (2016)

Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis

Por Zhang, Zhan-qing, Wang, Yan-bing, Lu, Wei, Liu, Dan-ping, Shi, Bi-sheng, Zhang, Xiao-nan, Huang, Dan, Li, Xiu-fen, Zhou, Xin-lan, Ding, Rong-rong
Publicado no Ann Lab Med (2019)

Phase IIb trial of in vivo electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy

Por Yang, Fu-Qiang, Rao, Gui-Rong, Wang, Gui-Qiang, Li, Yue-Qi, Xie, Yao, Zhang, Zhan-Qing, Deng, Cun-Liang, Mao, Qing, Li, Jun, Zhao, Wei, Wang, Mao-Rong, Han, Tao, Chen, Shi-Jun, Pan, Chen, Tan, De-Ming, Shang, Jia, Zhang, Ming-Xiang, Zhang, Yue-Xin, Yang, Ji-Ming, Chen, Guang-Ming
Publicado no World J Gastroenterol (2017)